SG11201608483PA - Drug delivery systems and related methods of use - Google Patents

Drug delivery systems and related methods of use

Info

Publication number
SG11201608483PA
SG11201608483PA SG11201608483PA SG11201608483PA SG11201608483PA SG 11201608483P A SG11201608483P A SG 11201608483PA SG 11201608483P A SG11201608483P A SG 11201608483PA SG 11201608483P A SG11201608483P A SG 11201608483PA SG 11201608483P A SG11201608483P A SG 11201608483PA
Authority
SG
Singapore
Prior art keywords
drug delivery
delivery systems
related methods
methods
systems
Prior art date
Application number
SG11201608483PA
Inventor
David Anderson
Original Assignee
Textile Based Delivery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Textile Based Delivery Inc filed Critical Textile Based Delivery Inc
Publication of SG11201608483PA publication Critical patent/SG11201608483PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SG11201608483PA 2014-05-30 2015-05-29 Drug delivery systems and related methods of use SG11201608483PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462005772P 2014-05-30 2014-05-30
PCT/US2015/033410 WO2015184407A1 (en) 2014-05-30 2015-05-29 Drug delivery systems and related methods of use

Publications (1)

Publication Number Publication Date
SG11201608483PA true SG11201608483PA (en) 2016-11-29

Family

ID=54699938

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201608483PA SG11201608483PA (en) 2014-05-30 2015-05-29 Drug delivery systems and related methods of use

Country Status (10)

Country Link
US (1) US20150342894A1 (en)
EP (1) EP3148494A4 (en)
JP (1) JP2017522365A (en)
KR (1) KR20170016884A (en)
CN (1) CN106456377A (en)
AU (1) AU2015266668A1 (en)
BR (1) BR112016025045A2 (en)
MX (1) MX2016014622A (en)
SG (1) SG11201608483PA (en)
WO (1) WO2015184407A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016069898A1 (en) * 2014-10-30 2016-05-06 Textile-Based Delivery, Inc. Delivery systems
CA3009697C (en) * 2016-01-04 2024-05-28 Jurox Pty Ltd Drug release device and use
WO2017147169A1 (en) * 2016-02-22 2017-08-31 Ohio State Innovation Foundation Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites
KR101957562B1 (en) * 2017-03-30 2019-06-20 재단법인대구경북과학기술원 Deformable Scaffold
WO2019222121A1 (en) * 2018-05-12 2019-11-21 Goldenbiotech, Llc Self-retaining implantable drug delivery device
SG11202005947RA (en) 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
WO2019226519A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
CN109821056A (en) * 2019-02-21 2019-05-31 南方科技大学 Embolic agent and preparation method and application thereof
CN110171814B (en) * 2019-05-13 2022-07-29 电子科技大学 Method for synthesizing carbon nanosheet by catalysis of water-soluble KCl and energy storage and sustained release application
CN111956869B (en) * 2020-08-07 2024-03-08 中南大学湘雅医院 A first part seed species slow promotion nerve growth is a pump of (2)
WO2023205140A1 (en) * 2022-04-18 2023-10-26 Colorado State University Research Foundation Thermoplastic elastomer composites, hydrogel composites, and gel polymer electrolyte composites

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4314557A (en) * 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
ATE293439T1 (en) * 2000-12-07 2005-05-15 Warner Lambert Co METHOD AND SYSTEM FOR EVEN DELIVERY OF DRUGS
WO2003017971A1 (en) * 2001-08-31 2003-03-06 Schering Oy Drug delivery system
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
CA2484632C (en) * 2002-05-07 2012-12-11 Control Delivery Systems, Inc. Processes for forming a drug delivery device
WO2004043435A2 (en) * 2002-11-13 2004-05-27 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
CN100512790C (en) * 2005-06-03 2009-07-15 华中科技大学 Zero order controlled releasing drug system and preparation method therof
AU2009298711B2 (en) * 2008-09-30 2015-10-29 Endo Pharmaceuticals Solutions Inc. Implantable device for the delivery of octreotide and methods of use thereof
EP2515864A4 (en) * 2009-12-23 2013-09-11 Psivida Inc Sustained release delivery devices
KR101914119B1 (en) * 2010-03-16 2018-11-02 타이탄 파머슈티컬즈 인코퍼레이티드 Heterogeneous implantable devices for drug delivery

Also Published As

Publication number Publication date
WO2015184407A1 (en) 2015-12-03
JP2017522365A (en) 2017-08-10
KR20170016884A (en) 2017-02-14
AU2015266668A1 (en) 2016-11-03
US20150342894A1 (en) 2015-12-03
EP3148494A4 (en) 2017-12-20
CN106456377A (en) 2017-02-22
MX2016014622A (en) 2017-05-04
BR112016025045A2 (en) 2017-08-15
EP3148494A1 (en) 2017-04-05

Similar Documents

Publication Publication Date Title
IL279001A (en) Nasal drug products and methods of their use
IL248730A0 (en) Drug delivery system and method of use
HK1254909A1 (en) Delivery of drug nanoparticles and methods of use thereof
EP3125866A4 (en) Refillable drug delivery devices and methods of use thereof
EP3209353A4 (en) Improved systems and methods for medicine delivery
IL246706B (en) Rapid action insulin formulations and pharmaceutical delivery systems
EP3142735A4 (en) Devices and methods for identification of medicament delivery devices
HK1245065A1 (en) Expandable drug delivery devices and methods of use
HK1215119A1 (en) Therapeutic product delivery system and method of pairing
IL280687B (en) Systems and methods for suture delivery
GB201421847D0 (en) Dispensers and methods of use thereof
SG11201608483PA (en) Drug delivery systems and related methods of use
EP3209362A4 (en) Redirecting delivery catheter and methods of use thereof
IL253157A0 (en) Systems and methods for improved delivery of
GB2537770B (en) Methods and processes for application of drug delivery polymeric coatings
IL245769A0 (en) Drug delivery device and method of use thereof
GB201419540D0 (en) Delivery of drugs
IL250814A0 (en) Insert and drug delivery device herewith
IL246874A0 (en) Drug delivery system
PT3519025T (en) Delivery device and associated methods of use
GB202008979D0 (en) Therapeutic product delivery system and method of pairing